IP Library Granted Patent US 8,551,505
Granted Patent B2
US 8,551,505 · App. 12/380,568 · Granted Oct 8, 2013

Compositions and methods for therapeutic delivery with frozen particles

Inventors: Edward S. Boyden (Cambridge, MA); Roderick A. Hyde (Redmond, WA); Eric C. Leuthardt (St. Louis, MO); Nathan P. Myhrvold (Medina, WA); Elizabeth A. Sweeney (Seattle, WA); Lowell L. Wood, Jr. (Bellevue, WA)
Assignee: The Invention Science Fund I, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,551,505
App. No.
12/380,568
Granted
Oct 8, 2013
Kind
B2
Abstract

Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one biological tissue.

Claims (31)

1. A method of providing at least one therapeutic agent to at least one biological tissue of a subject, comprising:

delivering at least one therapeutic composition including at least one anti-inflammatory agent to at least one biological tissue, wherein the at least one therapeutic composition includes one or more frozen particles including at least one frozen gas of helium, neon, xenon, krypton, or bromine, and

wherein delivering includes delivering by propulsion at a predetermined pressure.

2. The method of claim 1 , wherein the at least one therapeutic composition is propelled to a desired location of the at least one biological tissue.

3. The method of claim 1 , wherein delivering at least one therapeutic composition includes accelerating the therapeutic composition toward at least one biological tissue.

4. The method of claim 3 , wherein the at least one therapeutic composition is accelerated to a predetermined velocity for delivery of the at least one therapeutic composition to a desired location of the at least one biological tissue.

5. The method of claim 1 , wherein delivering at least one therapeutic composition to at least one biological tissue includes propelling a plurality of therapeutic compositions toward the at least one biological tissue.

6. The method of claim 1 , wherein delivering the at least one therapeutic composition occurs prior to, during, or subsequent to surgery.

7. The method of claim 1 , wherein the at least one biological tissue is located in at least one of in situ, in vitro, in vivo, in utero, in planta, or ex vivo.

8. The method of claim 1 , wherein the at least one biological tissue is transplanted or implanted into at least one subject.

9. The method of claim 7 , wherein the at least one biological tissue is ingested by at least one subject.

10. The method of claim 7 , wherein the at least one biological tissue includes at least one biological tissue from at least one donor or recipient.

11. The method of claim 7 , wherein the at least one biological tissue includes at least one cell mass.

12. The method of claim 11 , wherein the at least one cell mass includes at least one benign or malignant tumor.

13. The method of claim 1 , further including delivering to the at least one biological tissue at least one of a polymer, biopolymer, nanoparticle, or detection material.

14. The method of claim 13 , wherein the detection material includes at least one electronic identification device.

15. The method of claim 14 , wherein the at least one electronic identification device includes at least one radio frequency identification device.

16. The method of claim 13 , wherein the detection material includes at least one radioactive element.

17. The method of claim 13 , wherein the detection material includes at least one colorimetric substance.

18. The method of claim 13 , wherein the detection material includes at least one of a diamagnetic particle, ferromagnetic particle, paramagnetic particle, super paramagnetic contrast agent, or other magnetic particle.

19. The method of claim 1 , wherein the subject includes at least one invertebrate or vertebrate animal.

20. The method of claim 1 , wherein the subject includes at least one human.

21. The method of claim 19 , wherein the subject includes at least one of livestock, pet, undomesticated herd animal, wild animal, or a product animal.

22. The method of claim 1 , wherein the at least one therapeutic composition further includes one or more reinforcement agents.

23. The method of claim 1 , wherein the at least one therapeutic composition further includes one or more explosive materials.

24. A method of providing at least one therapeutic agent to at least one biological tissue, comprising:

delivering at least one therapeutic composition to at least one biological tissue of a subject;

wherein the at least one therapeutic composition includes one or more frozen particles including at least one frozen gas of helium, neon, xenon, krypton, bromine; and includes

paclitaxel; and wherein the delivering includes delivering by propulsion at a predetermined pressure.

25. The method of claim 24 , wherein the at least one therapeutic composition further includes one or more reinforcement agents.

26. The method of claim 24 , wherein the at least one therapeutic composition further includes one or more explosive materials.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2016
From: THE INVENTION SCIENCE FUND I LLC
To: GEARBOX, LLC
Reel/Frame 037540/0396 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2013
From: SEARETE LLC
To: THE INVENTION SCIENCE FUND I, LLC
Reel/Frame 031079/0634 →
Continuity (2)
Continuation In Part 12290686 · Oct 31, 2008
Related Publication 20100112093A1 · May 6, 2010